RadNet, Inc.
Informe acción DB:PQIA
Capitalización de mercado: €5.0b
Salud financiera de hoja de balance de RadNet
Salud financiera controles de criterios 4/6 RadNet tiene un patrimonio de accionistas total de $1.1B y una deuda total de $1.0B, lo que sitúa su ratio deuda-patrimonio en 91.1%. Sus activos y pasivos totales son $3.3B y $2.2B respectivamente. El BAIT de RadNet es de $117.1M, por lo que su ratio de cobertura de intereses es de 1.4. Tiene efectivo e inversiones a corto plazo que ascienden a $748.9M.
Información clave
91.1%
Ratio deuda-patrimonio
Ratio de cobertura de intereses 1.4x Efectivo US$748.92m Patrimonio US$1.12b Total pasivo US$2.16b Activos totales US$3.28b
Actualizaciones recientes sobre salud financiera
Mostrar todas las actualizaciones
Third quarter 2024 earnings released: EPS: US$0.044 (vs US$0.26 in 3Q 2023) Nov 11
RadNet, Inc. Revises Earnings Guidance for the Year 2024 Nov 11
RadNet, Inc. Appoints Cornelis “Kees” Wesdorp as President and Chief Executive Officer of its Digital Health Segment, Effective October 1, 2024 Sep 13
Insider recently sold €846k worth of stock Aug 23
Second quarter 2024 earnings released: US$0.041 loss per share (vs US$0.14 profit in 2Q 2023) Aug 08
New minor risk - Share price stability Aug 06
Insufficient new directors Jul 01
Executive VP recently sold €930k worth of stock Jun 13
First quarter 2024 earnings released: US$0.04 loss per share (vs US$0.36 loss in 1Q 2023) May 09
RadNet, Inc., Annual General Meeting, Jun 12, 2024 Apr 28 RadNet, Inc. has completed a Follow-on Equity Offering in the amount of $200.2 million.
Now 23% overvalued after recent price rise Mar 06
Full year 2023 earnings released: EPS: US$0.048 (vs US$0.19 in FY 2022) Mar 01
Insider recently sold €328k worth of stock Dec 08
RadNet, Inc. Launches a Pilot Inside Walmart of its New MammogramNow™ Offering Dec 07
RadNet, Inc. Unveils DeepHealth, a Pioneering AI-Powered Health Informatics Portfolio Nov 29
RadNet, Inc. Unveils DeepHealth, a Pioneering AI-Powered Health Informatics Portfolio Nov 28
Third quarter 2023 earnings released: EPS: US$0.26 (vs US$0.012 in 3Q 2022) Nov 10
New major risk - Financial position Aug 10
RadNet, Inc. Appoints Dr. Gregory Sorensen as Executive Vice President and Chief Science Officer Aug 10
Second quarter 2023 earnings released: EPS: US$0.14 (vs US$0.14 in 2Q 2022) Aug 09
Radnet, Inc. Revises Earnings Guidance for the Year 2023 Aug 09
RadNet, Inc. Announces Appointment of Executives Aug 02 RadNet, Inc. has completed a Follow-on Equity Offering in the amount of $225.35625 million. Jun 15
President & COO of Western Operations recently sold €1.3m worth of stock Jun 12
RadNet, Inc. Announces Ruth V. Wilson Did Not to Stand for Re-Election to the Board of Directors Jun 09
Board Member recently sold €128k worth of stock May 26
RadNet, Inc., Annual General Meeting, Jun 07, 2023 May 26
RadNet, Inc. Revises Earnings Guidance for the Year 2023 May 12
First quarter 2023 earnings released: US$0.36 loss per share (vs US$0.054 profit in 1Q 2022) May 12
President & COO of Eastern Operations recently sold €217k worth of stock Mar 19
Insider recently sold €418k worth of stock Mar 08
Full year 2022 earnings released: EPS: US$0.19 (vs US$0.47 in FY 2021) Mar 03
Radiology Imaging Associates Launches the Enhanced Breast Cancer Detection Program, Providing Women A New State-Of-The-Art Solution Powered by Artificial Intelligence Feb 07
President & COO of Western Operations recently sold €92k worth of stock Dec 21
Third quarter 2022 earnings released: EPS: US$0.012 (vs US$0.31 in 3Q 2021) Nov 11
RadNet, Inc. Provides Earnings Guidance for the Full Year of 2022 Nov 10
RadNet, Inc. (NasdaqGM:RDNT) acquired 75% stake in Heart & Lung Imaging Limited. Nov 02
Investor sentiment improved over the past week Sep 30
Investor sentiment improved over the past week Aug 17
Second quarter 2022 earnings released: EPS: US$0.14 (vs US$0.055 in 2Q 2021) Aug 11
RadNet, Inc. Updates Earnings Guidance for 2022 Aug 10
President & COO of Western Operations recently sold €193k worth of stock Jun 03
RadNet, Inc. Announces That It Has Received FDA Clearances for Its DeepHeatlh Saige-DX™ Mammography and Quantib® Prostate 2.0 MRI Artificial Intelligence ("Ai") Algorithms May 18
First quarter 2022 earnings released: EPS: US$0.054 (vs US$0.18 in 1Q 2021) May 11 RadNet, Inc. Revises Earnings Guidance for the Fiscal Year 2022 May 10
RadNet, Inc., Annual General Meeting, Jun 08, 2022 May 02
RadNet, Inc. Provides Earnings Guidance for the Fiscal Year 2022 Mar 04
Full year 2021 earnings: EPS in line with expectations, revenues disappoint Mar 03 RadNet, Inc. (NasdaqGM:RDNT) acquired Quantib B.V. for $45 million.
Third quarter 2021 earnings released: EPS US$0.31 (vs US$0.12 in 3Q 2020) Nov 10
Senior VP of Human Resources & Director recently sold €86k worth of stock Sep 04
Investor sentiment deteriorated over the past week Aug 16
Lead Independent Director recently bought €129k worth of stock Aug 14
Second quarter 2021 earnings released: EPS US$0.055 (vs US$0.21 loss in 2Q 2020) Aug 10
Senior VP of Human Resources & Director recently sold €388k worth of stock Jun 17
Independent Director Marvin Cadwell has left the company Jun 15
VP, Medical Director & Director John Crues has left the company Jun 15
Insider recently sold €404k worth of stock Jun 02
Independent Director recently bought €238k worth of stock May 19
First quarter 2021 earnings released: EPS US$0.18 (vs US$0.33 loss in 1Q 2020) May 12
RadNet, Inc. Revises Earnings Guidance for the Year 2021 May 11
Independent Director recently sold €397k worth of stock Mar 17
Full year 2020 earnings released: US$0.29 loss per share (vs US$0.30 profit in FY 2019) Mar 10
Revenue beats expectations Mar 10
New 90-day high: €19.90 Mar 10
RadNet and its Partner Dignity Health, Plaza Companies and Holualoa Companies Team Up to Redevelop Park Central Feb 11
New 90-day high: €17.00 Jan 07
President & COO of Western Operations recently sold €236k worth of stock Dec 03
Third quarter 2020 earnings released: EPS US$0.12 Nov 11
Revenue beats expectations Nov 11
New 90-day high: €15.80 Nov 11 Radnet Creates Operating Platform in Phoenix, Arizona Through New Joint Venture with Dignity Health/CommonSpirit Health
New 90-day low: €11.90 Sep 25
President & COO of Western Operations recently sold €262k worth of stock Sep 23
New 90-day low - €12.70 Aug 29
First half earnings released Aug 11
Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo ($1.0B) de PQIA superan a sus pasivos a corto plazo ($470.1M).
Pasivo a largo plazo: Los activos a corto plazo ($1.0B) de PQIA no cubren sus pasivos a largo plazo ($1.7B).
Historial y análisis de deuda-patrimonio
Nivel de deuda: El ratio deuda neta-patrimonio (24.2%) de PQIA se considera satisfactorio .
Reducción de la deuda: El ratio deuda-patrimonio de PQIA ha pasado de 326.6% a 91.1% en los últimos 5 años.
Cobertura de la deuda: La deuda de PQIA está bien cubierta por el flujo de caja operativo (27.4%).
Cobertura de intereses: Los pagos de intereses de la deuda de PQIA no están bien cubiertos por el BAIT (1.4x cobertura).
Descubre empresas con salud financiera Simply Wall St™ Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"control","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}